MAPT and Alzheimer disease: Studies show that 27-OHC is a risk factor for developing and aggravating AD pathology by disrupting cholesterol metabolism, reducing glucose uptake, activating the renin–angiotensin system (RAS) and increasing Aβ and phosphorylated tau protein in the brain, while 24S-OHC can be a protective factor in AD.